Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00890279Phase 2Unknown
A Phase 2 trial of cilnidipine in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Ministry of Health, Labour and Welfare. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00890279.